Dannce.ai Appoints Industry Leader to Board of Directors - Raymond Sanchez

Dannce.ai is proud to announce that Raymond Sanchez, M.D. has joined the company’s Board of Directors. Ray is a psychiatrist with over 20 years of experience in academia, medicine, and the pharmaceutical industry, specializing in areas including CNS and analgesia. He served as the chief medical officer of Cerevel Therapeutics until its acquisition by AbbVie in 2024 and is now a senior advisor at Bain Capital Life Sciences among other roles. Ray has a proven track record in global asset development, leading to regulatory approvals for multiple compounds, including Abilify® and Rexulti®. He has also played key roles in business development, capital formation, regulatory interactions, and strategic oversight of global medical portfolios across various therapeutic areas.